Redcare Pharmacy Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:SHPP.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Aug 25	SellUS$71,794	Theresa Holler	Individual	600	US$119.66
07 Aug 25	SellUS$213,182	Theresa Holler	Individual	1,800	US$118.43
06 Aug 25	SellUS$72,617	Theresa Holler	Individual	600	US$121.03
31 Jul 25	BuyUS$11,222	Jasper F. Eenhorst	Individual	100	US$112.22
05 Jun 25	BuyUS$114,508	L. Fastre	Individual	1,000	US$114.51
04 Jun 25	BuyUS$456,226	Michael Köhler	Individual	4,000	US$115.16
30 May 25	BuyUS$390,412	Michael Köhler	Individual	3,000	US$130.14
07 May 25	BuyUS$61,849	Frank Kohler	Individual	450	US$137.44
12 Mar 25	SellUS$293,559	Theresa Holler	Individual	2,000	US$146.78
07 Feb 25	BuyUS$51,827	Jerome Cochet	Individual	419	US$123.69
04 Feb 25	BuyUS$123,988	Frank Kohler	Individual	1,000	US$123.99
23 Jan 25	BuyUS$247,579	Frank Kohler	Individual	2,000	US$123.79
21 Jan 25	BuyUS$147,940	Frank Kohler	Individual	1,200	US$123.28

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SHPP.F?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	1,485,001	7.3%
Public Companies	2,054,591	10.1%
Individual Insiders	2,749,906	13.5%
Institutions	4,085,891	20.1%
General Public	9,967,097	49%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 61.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	Galenica AG	2,054,591	US$153.9m	0%	no data
7.3%	Mk Beleggingsmaatschappij Venlo	1,485,001	US$111.2m	0%	no data
4.77%	T. Rowe Price Group, Inc.	970,741	US$72.7m	-1.33%	0.01%
4.2%	Christoph Laubmann	854,384	US$64.0m	0%	no data
3.2%	Robert Hess	650,960	US$48.8m	0%	no data
3.16%	BlackRock, Inc.	642,138	US$48.1m	22.2%	no data
3.07%	The Vanguard Group, Inc.	624,107	US$46.7m	0.51%	no data
3.01%	Allianz Asset Management GmbH	611,354	US$45.8m	0%	0.04%
2.9%	Michael Köhler	590,850	US$44.3m	0%	no data
2.77%	Deutsche Asset & Wealth Management	564,229	US$42.3m	0%	0.01%
2.12%	Norges Bank Investment Management	430,720	US$32.3m	-29.4%	no data
1.94%	UBS Asset Management AG	394,728	US$29.6m	-56.3%	no data
1.63%	Frank Kohler	331,696	US$24.8m	0%	no data
1.6%	The Goldman Sachs Group, Inc.	325,260	US$24.4m	0%	0.01%
1.38%	JPMorgan Chase & Co.	281,464	US$21.1m	17.5%	no data
1.26%	Union Asset Management Holding AG	255,718	US$19.2m	0%	0.01%
1.21%	Barclays Bank PLC	245,756	US$18.4m	-2.62%	0.02%
0.99%	Merrill Lynch, Pierce, Fenner & Smith Incorporated	202,256	US$15.1m	0%	no data
0.98%	Grandeur Peak Global Advisors, LLC	198,350	US$14.9m	6.05%	0.49%
0.97%	Société Générale Société anonyme	196,546	US$14.7m	142%	0.05%
0.86%	Invesco Capital Management LLC	175,533	US$13.1m	0.24%	no data
0.73%	Theresa Holler	148,995	US$11.2m	-1.97%	no data
0.54%	L. Fastre	110,055	US$8.2m	0%	no data
0.5%	Lupus Alpha Asset Management GmbH	101,300	US$7.6m	0%	0.53%
0.4%	Amundi Asset Management SAS	81,161	US$6.1m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/19 15:49
End of Day Share Price	2026/01/08 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Redcare Pharmacy NV is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gerhard Schwarz	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Alvira Rao	Barclays